Sodium-glucose co-transporter-2 inhibitors (SGLT2i) use and risk of amputation: an expert panel overview of the evidence
N Katsiki, G Dimitriadis, G Hahalis, N Papanas… - Metabolism, 2019 - Elsevier
Abstract Sodium-glucose co-transporter-2 inhibitors (SGLT2i) are oral antidiabetic agents
that exert their glucose-lowering effect by increasing renal excretion of glucose. These drugs …
that exert their glucose-lowering effect by increasing renal excretion of glucose. These drugs …
Sodium-glucose co-transporter-2 inhibitors (SGLT2i) use and risk of amputation: an expert panel overview of the evidence.
N Katsiki, G Dimitriadis, G Hahalis… - Metabolism: Clinical …, 2019 - europepmc.org
Sodium-glucose co-transporter-2 inhibitors (SGLT2i) are oral antidiabetic agents that exert
their glucose-lowering effect by increasing renal excretion of glucose. These drugs have …
their glucose-lowering effect by increasing renal excretion of glucose. These drugs have …
Sodium-glucose co-transporter-2 inhibitors (SGLT2i) use and risk of amputation: an expert panel overview of the evidence
N Katsiki, G Dimitriadis, G Hahalis… - Metabolism …, 2019 - pubmed.ncbi.nlm.nih.gov
Sodium-glucose co-transporter-2 inhibitors (SGLT2i) are oral antidiabetic agents that exert
their glucose-lowering effect by increasing renal excretion of glucose. These drugs have …
their glucose-lowering effect by increasing renal excretion of glucose. These drugs have …
[PDF][PDF] Sodium-glucose co-transporter-2 inhibitors (SGLT2i) use and risk of amputation: an expert panel overview of the evidence☆
N Katsiki, G Dimitriadis, G Hahalis, N Papanas… - Metabolism Clinical …, 2019 - siditalia.it
Niki Katsiki a,⁎, 1, George Dimitriadis b, George Hahalis c, Nikolaos Papanas d, Nikolaos
Tentolouris e, Filippos Triposkiadis f, Vasilios Tsimihodimos g, Costas Tsioufis h, Dimitri P …
Tentolouris e, Filippos Triposkiadis f, Vasilios Tsimihodimos g, Costas Tsioufis h, Dimitri P …
Sodium-glucose co-transporter-2 inhibitors (SGLT2i) use and risk of amputation: an expert panel overview of the evidence
N Katsiki, G Dimitriadis, G Hahalis… - Metabolism …, 2019 - metabolismjournal.com
Abstract Sodium-glucose co-transporter-2 inhibitors (SGLT2i) are oral antidiabetic agents
that exert their glucose-lowering effect by increasing renal excretion of glucose. These drugs …
that exert their glucose-lowering effect by increasing renal excretion of glucose. These drugs …